Akhil Kapoor: Intensifying Chemotherapy in advanced Gastric Cancer doesn’t improve survivals

Akhil Kapoor, Associate Professor and Medical Oncology at TMH Varanasi, shared a post on X:

“Our Multicenter study led by Vikas Ostwal and Anant Ramaswamy published in Journal of the National Cancer Institute (JNCI) .

Intensifying Chemotherapy in advanced Gastric Cancer doesn’t improve survivals.

• Increases toxicities.
•  More is not always better.”

Docetaxel-oxaliplatin-capecitabine/5 fluorouracil (DOC/F) followed by docetaxel versus Oxaliplatin-Capecitabine/5 fluorouracil (CAPOX/mFOLFOX-7) in HER2 negative advanced gastric cancers published in JNCI.

Authors: Anant Ramaswamy, Prabhat Bhargava, Biswajit Dubashi, Anuj Gupta, Akhil Kapoor, Sujay Srinivas, Omshree Shetty, Poonam Jadhav, Veena Desai, Vanita Noronha, Amit Joshi, Nandini Menon, Vijay M Patil, Bal Krishna Mishra, Bipinesh Sansar,Arpita Singh, Swapnil Patel, Satyendra Narayan Singh, Ipsita Dhal, Kunal Ranjan Vinayak, Vikash Pal, Sarika Mandavkar, Sadhana Kannan Biostatistician, Deepali Chaugule, Rajshree Patil, Manali Parulekar, Chaitali Nashikkar, Suman Kumar Kushal, Aekta Shah, Prasanth Ganesan, Smita Kayal, Ramesh Ananthakrishnan, Syed Noorzia, Debdeep Samaddar, Venkatesh, Kapu, Anokhi Shah, Kaaviya D, Suganiya R, Nirmala Devi Srinivasan, Kumar Prabhash, Vikas Ostwal.

Additional information
Source: Akhil Kapoor/X